Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder

Jeanne M Madden1,2, Matthew D Lakoma3, Frances L Lynch4

  • 1Department of Pharmacy and Health Systems Sciences, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, 360 Huntington Avenue R218X TF, Boston, MA, 02115, USA. j.madden@northeastern.edu.

Insights

Nearly half of children with autism spectrum disorder (ASD) use psychotropic medications, significantly more than their peers. This highlights treatment challenges and the need for more research on medication effectiveness in ASD.

Area of Science:

  • Pediatric Psychiatry
  • Neurodevelopmental Disorders
  • Pharmacology

Background:

  • Autism spectrum disorder (ASD) is a complex neurodevelopmental condition.
  • Psychotropic medication use in children with ASD is a growing concern.
  • Limited evidence exists for the efficacy of many psychotropic medications in pediatric ASD populations.

Purpose of the Study:

  • To examine the prevalence of psychotropic medication use in children with ASD.
  • To compare psychotropic medication use in children with ASD to matched controls without ASD.
  • To identify common classes of psychotropic medications prescribed to children with ASD.

Main Methods:

  • Retrospective cohort study involving 7901 children aged 1-17 with ASD.
  • Comparison with matched cohorts of children without ASD across five health systems.
  • Analysis of psychotropic medication classes including stimulants, alpha-agonists, atomoxetine, antipsychotics, and antidepressants.

Main Results:

  • 48.5% of children with ASD received psychotropic medications.
  • Psychotropic use was significantly higher in children with ASD (48.5%) compared to controls (7.7%).
  • Commonly prescribed classes were stimulants/alpha-agonists/atomoxetine (30.2%), antipsychotics (20.5%), and antidepressants (17.8%).

Conclusions:

  • Psychotropic medication use is highly prevalent in children with ASD.
  • Disparities in psychotropic use exist between children with and without ASD, even when controlling for other psychiatric diagnoses.
  • The findings underscore the need for improved evaluation and evidence-based treatment strategies for ASD.

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.5K
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
643
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
364
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
1.0K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
648